Cargando…
Heterologous Boost Following Mycobacterium bovis BCG Reduces the Late Persistent, Rather Than the Early Stage of Intranasal Tuberculosis Challenge Infection
Adults are the leading population affected by tuberculosis (TB) epidemic and death. Developing an effective vaccine against adult TB is urgently needed. Mycobacterium bovis Bacillus Calmette-Guerin (BCG) prime-heterologous boost strategy has been explored extensively to protect adults against primar...
Autores principales: | Wu, Yaqi, Cai, Ming, Ma, Jilei, Teng, Xindong, Tian, Maopeng, Bassuoney, Eman Borham Mohamed Borham, Fan, Xionglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218689/ https://www.ncbi.nlm.nih.gov/pubmed/30425711 http://dx.doi.org/10.3389/fimmu.2018.02439 |
Ejemplares similares
-
A Multistage Subunit Vaccine Effectively Protects Mice Against Primary Progressive Tuberculosis, Latency and Reactivation
por: Ma, Jilei, et al.
Publicado: (2017) -
Label-Free Comparative Proteomics of Differentially Expressed Mycobacterium tuberculosis Protein in Rifampicin-Related Drug-Resistant Strains
por: Ullah, Nadeem, et al.
Publicado: (2021) -
Recombinant AhpC antigen from Mycobacterium bovis boosts BCG-primed immunity in mice
por: DÜZENLİ, Özgün Fırat, et al.
Publicado: (2021) -
Vaccination-related Mycobacterium bovis BCG Infection
por: Liberek, Anna, et al.
Publicado: (2006) -
Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives
por: Dellagostin, Odir Antônio, et al.
Publicado: (2022)